Literature DB >> 9878041

Normal IgG and impaired IgM responses to polysaccharide vaccines in asplenic patients.

D C Molrine1, G R Siber, Y Samra, D S Shevy, K MacDonald, R Cieri, D M Ambrosino.   

Abstract

Asplenic patients are at increased risk for life-threatening infections with polysaccharide-encapsulated organisms, and reports of responses to polysaccharide vaccines have been conflicting. Thirty-six asplenic patients and 15 healthy controls were immunized with pneumococcal, Haemophilus influenzae type b (Hib), and meningococcal vaccines. Antibody concentrations to Hib and pneumococcal serotypes 14 and 18C were measured by ELISA. IgG antibody responses to all three antigens were similar in asplenic patients and controls at 28 days following immunization. In contrast, asplenic patients had significantly lower IgM concentrations in response to Hib (P<.05) and to both pneumococcal serotypes 14 (P<. 005) and 18C (P<.001). IgA anti-Hib antibody was also lower in the asplenic group, as was total anti-Hib antibody measured by RIA. These results document that IgG responses to polysaccharide vaccines are normal in asplenic patients. The impaired IgM responses of these patients may explain conflicting reports from studies that measured only total antibody-binding concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878041     DOI: 10.1086/314582

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides.

Authors:  M A Breukels; A Zandvoort; G P van Den Dobbelsteen; A van Den Muijsenberg; M E Lodewijk; M Beurret; P A Klok; W Timens; G T Rijkers
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals.

Authors:  Paul Balmer; Michelle Falconer; Paula McDonald; Nick Andrews; Emily Fuller; Christine Riley; Edward Kaczmarski; Raymond Borrow
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Memory B cells and pneumococcal antibody after splenectomy.

Authors:  Heather Wasserstrom; James Bussel; Lony C-L Lim; Charlotte Cunningham-Rundles
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

4.  The immunity features and defects against primary cytomegalovirus infection post-splenectomy indicate an immunocompromised status: A PRISMA-compliant meta-analysis.

Authors:  George Dimitrios Liatsos
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

5.  Riddle Me This: Acalculous Cholecystitis as an Unusual Complication of Immunoglobulin M Negative Mononucleosis.

Authors:  Philipp Höhn; Chris Braumann; Waldemar Uhl; Andreas M Luu
Journal:  Cureus       Date:  2018-04-19

6.  B-1a Cell Development in Splenectomized Neonatal Mice.

Authors:  Gabriel K Pedersen; Xiaohong Li; Sharesta Khoenkhoen; Monika Ádori; Bruce Beutler; Gunilla B Karlsson Hedestam
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

7.  Effectiveness of Haemophilus influenzae type b vaccination after splenectomy - impact on selected immunological parameters.

Authors:  Ewelina Grywalska; Dorota Siwicka-Gieroba; Michał Mielnik; Martyna Podgajna; Krzysztof Gosik; Wojciech Dąbrowski; Jacek Roliński
Journal:  Hum Vaccin Immunother       Date:  2018-11-05       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.